Dihydroartemisinin: A promising therapeutic agent against the hepatiti

Introduction

Liver cancer, especially hepatocellular carcinoma(HCC), is the fifth most common cancer worldwide and the third leading cause of cancer mortality.¹ Asia is a major region for liver cancer, and Asia reported 72.5% of the world’s…